Format

Send to

Choose Destination
Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26902. Epub 2017 Nov 28.

Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma.

Author information

1
Department of Oncology for Children and Adolescents, Gustave Roussy Caner Campus, Villejuif, France.
2
Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
3
Department of Clinical Research, Gustave Roussy Cancer Campus, Villejuif, France.
4
Department of Haematology, Hôpital Saint Antoine, Paris, France.
5
Department of Medecine, Centre Hospitalier de la Polynésie Française, Papeete, Polynésie Française.
PMID:
29193772
DOI:
10.1002/pbc.26902

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center